Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

The Effect of a Prolonged Peripheral Nerve Block (Utilazing Continuous Adductor Canal Block on the Level of Pain After a Knee Replacement Surgery

ID
Name
0206-22-ASF
Description
The aim of this study is to examine the effect of a prolonged peripheral nerve block (utilizing continuous adductor canal block) on the level of pain after a knee replacement surgery
Trial arms
Trial start
2024-10-30
Estimated PCD
2025-10-30
Trial end
2026-01-31
Status
Not yet recruiting
Treatment
Continues peripheral block
ropivacaine (Naropin) 0.2% according to a protocol 8-10 cc per hour up to 24 hours after surgery
Arms:
Control group, Treatment group
Other names:
Treatment group
Size
50
Primary endpoint
Pain level
during hospitalization (1-2 days)
Analgesic use
during hospitalization (1-2 days)
Eligibility criteria
Inclusion Criteria: * Female and male patients between the ages of 18 and 80 who have signed an informed consent form. * ASA is less than 3 * Spinal anesthesia Exclusion Criteria: * Patients with sensitivity to the anesthetic.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'The study will include 50 patients who underwent a knee replacement surgery, who will be randomized to 2 groups. 6 hours after surgery the two groups will be connected to a prolonged block pump. One group will receive the peripheral block ropivacaine 0.2% according to the protocol of 8-10 cc per hour up to 24 hours after surgery. The second group will receive saline according to the same protocol', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 50, 'type': 'ESTIMATED'}}
Updated at
2024-04-24

1 organization

1 product

1 indication

Organization
Assaf-Harofeh Medical Center
Product
Continues peripheral block
Indication
Total Knee Arthroplasty